ALVO - Alvotech
8.06
-0.260 -3.226%
Share volume: 210,875
Last Updated: 04-08-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.07%
PREVIOUS CLOSE
CHG
CHG%
$8.32
-0.26
-0.03%
Fundamental analysis
0%
Profitability
0%
Dept financing
0%
Liquidity
0%
Performance
0%
Performance
5 Days
-5.18%
1 Month
-24.67%
3 Months
-40.38%
6 Months
-37.90%
1 Year
-32.44%
2 Year
-39.26%
Key data
Stock price
$8.06
DAY RANGE
$8.04 - $8.89
52 WEEK RANGE
$7.77 - $14.76
52 WEEK CHANGE
-$32.15
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-20-2025
Company detail

CEO: Mark L. PhD
Region: US
Website: alvotech.com
Employees: 4
IPO year: 2022
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Sector: Manufacturing
Region: US
Website: alvotech.com
Employees: 4
IPO year: 2022
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Sector: Manufacturing
N/A
Recent news
